The Flow Cytometry Facility serves the UCCRC members by providing access to state-of-the-art technology, and quantitative analytical approaches to measure molecular and cellular function. The Facility is designed to meet the wide-spread needs for specialized cytologic analysis, and continues to respond to the demand for new and improved technology. The Facility's mission is three-fold: 1) To provide cutting-edge technology and expertise; 2) To pursue technology and application development;and 3) To provide education and training of researchers. The first goal is attained with state-of-the-art instrumentation and continuing education for the expert personnel. Technology and application development involves close relationships with Cancer Research Center researchers who are continually looking for new methods to address their scientific questions. Educational goals are satisfied by providing application workshops, training sessions, and one-on-one protocol development and consultation. The Facility also provides an extensive reference library containing references pertinent to its technological focus. The Facility's Scientific Director (Dr. Anne Sperling) and Technical Director (Mr. Ryan Duggan) provide direct oversight of the operation of the Flow Cytometry Facility. A Faculty Advisory Committee (FAC) is advisory to the Facility personnel with regards to services, scientific direction, and fiscal issues. The Facility is utilized by UCCRC investigators in many areas of study involved in the basic research of cellular function. The Flow Cytometry Facility provides instrumentation for the analytical detection of subcellular components using multiparametric fluorescence detection technology. Another key component of the Facility is its cell sorting instruments that allow the fractionation and purification of subpopulations of cells from a heterogeneous single cell suspension. The Flow Cytometry Facility has increased its cell sorting and bench-top analyzer capacity to meet investigator demand, resulting in more than a 300% increase in overall Facility usage since the 2001 CCSG renewal. Over 52 peerreviewed UCCRC investigators across five Scientific Programs routinely use the Flow Cytometry Facility, totaling 80% of Facility usage.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-35
Application #
8105367
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
35
Fiscal Year
2010
Total Cost
$180,243
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966
Sample, Ashley; Zhao, Baozhong; Wu, Chunli et al. (2018) The Autophagy Receptor Adaptor p62 is Up-regulated by UVA Radiation in Melanocytes and in Melanoma Cells. Photochem Photobiol 94:432-437
Hrusch, C L; Manns, S T; Bryazka, D et al. (2018) ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol 11:61-70
Hope, C Matthew; Webber, Jemma L; Tokamov, Sherzod A et al. (2018) Tuned polymerization of the transcription factor Yan limits off-DNA sequestration to confer context-specific repression. Elife 7:
Wong, Gabrielle S; Zhou, Jin; Liu, Jie Bin et al. (2018) Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nat Med 24:968-977

Showing the most recent 10 out of 668 publications